These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20533174)

  • 1. Breast cancer and diabetes mellitus.
    Schott S; Schneeweiss A; Sohn C
    Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):673-7. PubMed ID: 20533174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes mellitus and increased risk of cancer: focus on metformin and the insulin analogs.
    McFarland MS; Cripps R
    Pharmacotherapy; 2010 Nov; 30(11):1159-78. PubMed ID: 20973689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased prevalence of prior breast cancer in women with newly diagnosed diabetes.
    Lipscombe LL; Goodwin PJ; Zinman B; McLaughlin JR; Hux JE
    Breast Cancer Res Treat; 2006 Aug; 98(3):303-9. PubMed ID: 16538527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diabetes, insulin, insulin analogues, and cancer].
    Müssig K; Staiger H; Kantartzis K; Fritsche A; Kanz L; Häring HU
    Dtsch Med Wochenschr; 2010 May; 135(18):924-9. PubMed ID: 20425680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological aspects of neoplasms in diabetes.
    Nicolucci A
    Acta Diabetol; 2010 Jun; 47(2):87-95. PubMed ID: 20376506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents.
    Goodwin PJ; Stambolic V; Lemieux J; Chen BE; Parulekar WR; Gelmon KA; Hershman DL; Hobday TJ; Ligibel JA; Mayer IA; Pritchard KI; Whelan TJ; Rastogi P; Shepherd LE
    Breast Cancer Res Treat; 2011 Feb; 126(1):215-20. PubMed ID: 20976543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes mellitus type 2 - an independent risk factor for cancer?
    Grote VA; Becker S; Kaaks R
    Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):4-8. PubMed ID: 20127570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is it time to test metformin in breast cancer clinical trials?
    Cazzaniga M; Bonanni B; Guerrieri-Gonzaga A; Decensi A
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):701-5. PubMed ID: 19240238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of diabetes with mammographic breast density and breast cancer in the Minnesota breast cancer family study.
    Sellers TA; Jensen LE; Vierkant RA; Fredericksen ZS; Brandt KR; Giuliano AR; Pankratz VS; Cerhan JR; Vachon CM
    Cancer Causes Control; 2007 Jun; 18(5):505-15. PubMed ID: 17437179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing antidiabetic treatment options for patients with type 2 diabetes mellitus and cardiovascular comorbidities.
    Malesker MA
    Pharmacotherapy; 2008 Feb; 28(2):193-206. PubMed ID: 18225965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer risk in diabetic patients treated with insulin glargine?
    Prescrire Int; 2010 Aug; 19(108):162-3. PubMed ID: 20939447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes and the risk of prostate cancer: the role of diabetes treatment and complications.
    Velicer CM; Dublin S; White E
    Prostate Cancer Prostatic Dis; 2007; 10(1):46-51. PubMed ID: 17033617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of malignancies in patients with insulin-treated diabetes mellitus: results of a population-based trial with 10-year follow-up (JEVIN).
    Schiel R; Müller UA; Braun A; Stein G; Kath R
    Eur J Med Res; 2005 Aug; 10(8):339-44. PubMed ID: 16131475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes, insulin, and risk of cancer.
    Schiel R; Beltschikow W; Steiner T; Stein G
    Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):169-75. PubMed ID: 16810343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sitagliptin: a novel drug for the treatment of type 2 diabetes.
    Choy M; Lam S
    Cardiol Rev; 2007; 15(5):264-71. PubMed ID: 17700385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin: "Old warrior for a new battle".
    Jain A
    Indian J Cancer; 2010; 47(4):471-2. PubMed ID: 21131766
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin glargine and cancer risk: an opinion statement of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy.
    Edwards KL; Riche DM; Stroup JS; Goldman-Levine JD; Padiyara RS; Cross LB; Kane MP
    Pharmacotherapy; 2010 Sep; 30(9):955-65. PubMed ID: 20795850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gynecologic neoplasms in diabetic patients].
    Melichar B
    Vnitr Lek; 2002 Dec; 48(12):1123-9. PubMed ID: 12642926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin and cancer: licence to heal?
    Papanas N; Maltezos E; Mikhailidis DP
    Expert Opin Investig Drugs; 2010 Aug; 19(8):913-7. PubMed ID: 20557275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between diabetes mellitus and adverse characteristics of breast cancer at presentation.
    Wolf I; Sadetzki S; Gluck I; Oberman B; Ben-David M; Papa MZ; Catane R; Kaufman B
    Eur J Cancer; 2006 May; 42(8):1077-82. PubMed ID: 16574404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.